Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daryl Freeman

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Respiration; International Review of Thoracic Diseases|December 7, 2005
Symptom-based questionnaire for differentiating COPD and asthmaDavid G Tinkelman, David B Price, Robert J Nordyke, et al.
Respiration; International Review of Thoracic Diseases|December 7, 2005
Symptom-based questionnaire for identifying COPD in smokersDavid B Price, David G Tinkelman, R J Halbert, et al.
International Journal of Chronic Obstructive Pulmonary Disease|May 28, 2025
Single-Inhaler Triple Therapy in Primary Care Across Europe: Expert Panel Consensus on the Consequences of Payer-Driven Access Rules and Call to ActionFabiano Di Marco, Orjola Shahaj, Arschang Valipour, et al.
The Lancet. Respiratory Medicine|April 11, 2014
Opportunities to diagnose chronic obstructive pulmonary disease in routine care in the UK: a retrospective study of a clinical cohortRupert C M Jones, David Price, Dermot Ryan, et al.
Pharmacoeconomics|June 17, 2010
Cost effectiveness of leukotriene receptor antagonists versus inhaled corticosteroids for initial asthma controller therapy: a pragmatic trialEdward C F Wilson, Erika J Sims, Stanley D Musgrave, et al.
Pharmacoeconomics|May 8, 2010
Cost effectiveness of leukotriene receptor antagonists versus long-acting beta-2 agonists as add-on therapy to inhaled corticosteroids for asthma: a pragmatic trialEdward C F Wilson, David Price, Stanley D Musgrave, et al.
The New England Journal of Medicine|May 6, 2011
Leukotriene antagonists as first-line or add-on asthma-controller therapyDavid Price, Stanley D Musgrave, Lee Shepstone, et al.
The European Respiratory Journal|July 22, 2017
Blood eosinophil count and exacerbation risk in patients with COPDMarjan Kerkhof, Samatha Sonnappa, Dirkje S Postma, et al.
The Lancet. Respiratory Medicine|November 8, 2017
Fractional exhaled nitric oxide as a predictor of response to inhaled corticosteroids in patients with non-specific respiratory symptoms and insignificant bronchodilator reversibility: a randomised controlled trialDavid B Price, Roland Buhl, Adrian Chan, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Respiration; International Review of Thoracic Diseases|December 7, 2005
Symptom-based questionnaire for differentiating COPD and asthmaDavid G Tinkelman, David B Price, Robert J Nordyke, et al.
Respiration; International Review of Thoracic Diseases|December 7, 2005
Symptom-based questionnaire for identifying COPD in smokersDavid B Price, David G Tinkelman, R J Halbert, et al.
International Journal of Chronic Obstructive Pulmonary Disease|May 28, 2025
Single-Inhaler Triple Therapy in Primary Care Across Europe: Expert Panel Consensus on the Consequences of Payer-Driven Access Rules and Call to ActionFabiano Di Marco, Orjola Shahaj, Arschang Valipour, et al.
The Lancet. Respiratory Medicine|April 11, 2014
Opportunities to diagnose chronic obstructive pulmonary disease in routine care in the UK: a retrospective study of a clinical cohortRupert C M Jones, David Price, Dermot Ryan, et al.
Pharmacoeconomics|June 17, 2010
Cost effectiveness of leukotriene receptor antagonists versus inhaled corticosteroids for initial asthma controller therapy: a pragmatic trialEdward C F Wilson, Erika J Sims, Stanley D Musgrave, et al.
Pharmacoeconomics|May 8, 2010
Cost effectiveness of leukotriene receptor antagonists versus long-acting beta-2 agonists as add-on therapy to inhaled corticosteroids for asthma: a pragmatic trialEdward C F Wilson, David Price, Stanley D Musgrave, et al.
The New England Journal of Medicine|May 6, 2011
Leukotriene antagonists as first-line or add-on asthma-controller therapyDavid Price, Stanley D Musgrave, Lee Shepstone, et al.
The European Respiratory Journal|July 22, 2017
Blood eosinophil count and exacerbation risk in patients with COPDMarjan Kerkhof, Samatha Sonnappa, Dirkje S Postma, et al.
The Lancet. Respiratory Medicine|November 8, 2017
Fractional exhaled nitric oxide as a predictor of response to inhaled corticosteroids in patients with non-specific respiratory symptoms and insignificant bronchodilator reversibility: a randomised controlled trialDavid B Price, Roland Buhl, Adrian Chan, et al.
Pageof 3